Member Info for keiny1

Bit of a disappointing sp reaction to the trial approval… was hoping it would be at least 10% if not 20% given the recent slow retrace. Anyway another step forward I guess.

That’d be nice here, may come one day

Yeah agree with you Violin… we’ve been used as required and even then PR and Comms weren’t the best. I still hope to see a £1+ sp here so I’ll be sticking it out to at least the first commercial deal of substance to assess where it values things, and decide to hold, reduce or fully sell out. I’d prefer a TO tbh as it’s simple, but may not achieve the most value if a number of licenses were to be agreed instead. Anyway GLA

If you believe in the codes...looks like MMs short on shares so may see a Friday rise to attract some sells!

Not much going on here, could do with a little news on anything really to kickstart some upward trend.

That the Sp didn’t move north a bit more a hold a 10-15% rise, but maybe we’ll see that tomorrow. Looks like news will be forthcoming as trials are recruited abs commenced following approval to run. Also interesting to read about the shell company set up and wondering what that’s all about. Possible it’s a start of separating the various IP and platforms for licence or TO agreements to come. We can hope, GLA, still anticipating the rest of this year to be positive as the Bod builds the commercializations possibilities into 2022.

we didn't hang on in the 8-8.5p range, but still a gain.

Anyway. lets see what happens tomorrow...some chunky buts in the high 7's and a very high 9p+, so you'd think somethings afoot and that those sahres won't be sold soon either.

GLA, If we have a 10p Party in Vancouver I can be there :) ...looking forward to the realisation of profit after teh 10+ yrs I've held strong!

Such a strange post.... just because you’ve not used this training doesn’t mean no one has? Typical ‘I know better and best’ comment with no basis. How about a comment like ‘Wow, I do iron man events and haven’t ever trained that long, why do you and how do you find it? Same approach should be used for any different opinions here unless they are factually right or wrong. Back to the science and company now, where we seem to have a much more aligned board here recently which has been great!

Purely a frustrated post... but the Sclp PR machine seems to back in the lock up or even reversing through the back door. Surprised that with 2 larger Backers on board that they haven’t pushed into a more PR focused outlook after the media coverage and so rise. Still nothing we know of being wrong with the science thought GLA, hoping for a happy summer here!

Also clears the RNS decks for the good stuff rather then including something negative in a transformational RNS in a few weeks GLA

Yes we are in need of a PR kick here to keep the SP around the mid 20s. Shame nothing much more has come in the last month.

Hey Ahfam, The point wasn’t really the prices, more that could we have offers tabled now before it could potentially be 5,10,15 times the price. Anyway we will see how it all plays out in the next 3-6 months I’m sure!

Being optimistic and with the amount of data/reviews indicating that Sar do have something of value, if not yet 100% proven you'd be surely of expecting a Pharma to potentially table an offer for license or for TO before the complete results come in, hoping they can get for 10p PS rather than 30p PS for example? Or there are NDA's in place an loose terms agreed when and if 1801 gets the green light.

Anyway going to be an interesting ride for sure from here on in. Ups & downs still, but the possibility of the shooting star RNS is there for everyone to see now! GLA

Thanks Cumbs and Loch I didn’t manage to see the presentation yet and maybe I should have routes that out first. Will watch it cheers

Just reading through the website to re-confirm what SCLP actually have in the pipeline, but there's some detail lacking on the most recent date sand timelines... most likley as thing shave drifted due to COVID for all the cancer progress.

However, does anyone have a projected timeline for the next news on each product/candidate... just as a quick overview of what may be expected short and medium term. Had been hoping that the Biontech collab would have brought more development/news than it has thus far.
Anyway just something to discuss whilst we hold for Covid news I hope, cheers

Agree, somewhat of a pause in the expected news flow at the moment due to the simple fact that things take time to test/progress and data to be obtained. Still think we could have a full TO of the company in 2021, but it may not be the 20p+ that some are hoping for unless they really hit the bullseye with a Tyk2 deal. I'll be holding until a deal/licenses at least part values the IP in the company and then assess from there.

Well not really that funny, but never allowed it to run up again after lunch and a sea of buys.

Anyway, we will wait for some positive news again for the next leg up. Hoping we can get above 2p as a base again before anything pivotal happens.

Yes it certainly seems like a little nod in the direction of the BOD being confident that they can access this funding if required.... therefore reducing the need/pressure for other funding right now!

Hoping things got up a little soon and we see some positive sentiment and news flow GLA

This is the very logical route now and I don’t think Redmile and Vulpes will want SCLP to miss this opportunity to significantly increase its Mcap and industry standing by letting these developments drift away.

Will a partner be waiting in the wings for an announcement this week or next... or at SCLP looking to maximize any potential partnership and wait the extra few weeks for the first human trial date? If that’s good then I’d say mega money and a vaccine ready for use before end of this year with the right backing.

And again this is an ‘extra’ opportunity on top of the excellent cancer pipelines. GLA

Thanks AB,

In reality I’m assuming Vulpes and then Redmile especially have been doing nothing but pushing the data/IP to their connections since arriving.

Just my turn to be a little bit frustrated with the lack of positive PR!

with the decline back from 17-18p when we thought we had some good sentiment and news/or coming... BOD need to get their **** together a little bit here or risk the continued overlooking by partners!!

Or the optimist in me thinks there’s a deal being ironed out... as how could the IP here be that ignored?

GLA